Obesity Medication Bill in Kingdom to Cost 28 Billion Riyals
A recent Saudi study estimates that the cost of treating obesity in the Kingdom could reach 28.3 billion riyals over ten years, should coverage expand to include all adults. It suggests that the government sector would bear around 18.9 billion riyals, while the private sector would contribute approximately 9.4 billion riyals. The study indicates that about 5.46 million adults suffer from obesity, with 58% of them experiencing serious comorbidities. Treatment costs for the higher-risk groups are projected at around 3.98 billion riyals over five years and could rise to 16.64 billion riyals over the decade. The modeling results confirm that the price of medication and the level of demand are the most significant factors influencing costs. The study recommends careful financial management and price negotiations, prioritizing patients at greater health risk.
Notice: This Is an AI-Generated Summary
Comments (0)